by Family Voices, Inc. | Jan 5, 2022 | Family Voices, Vaccine Outreach
Advisers to the Centers for Disease Control and Prevention recommended that children 12- to 17-years-old should get a Pfizer-BioNTech coronavirus vaccine booster, voting to expand protection to millions of adolescents and teens as surging infections threaten to...
by Family Voices, Inc. | Jan 5, 2022 | Family Voices, Vaccine Outreach
Children ages 5 to 11 are now eligible for the coronavirus vaccine in the United States since the Centers for Disease Control and Prevention signed off on the two-shot Pfizer-BioNTech series for about 28 million additional children. Read More…
by Family Voices, Inc. | Jan 5, 2022 | Family Voices, Vaccine Outreach
Omicron has sparked alarm among health experts worried about the new variant’s ability to spread rapidly and evade the body’s immune defenses. Scientists are racing to learn more as cases rise. Read more…
by Family Voices, Inc. | Jan 5, 2022 | Family Voices, Vaccine Outreach
As millions of Americans scramble to navigate life disrupted by the easily transmissible omicron variant, public officials are urging them to view at-home antigen tests as an important tool to stem the surge in coronavirus cases and hospitalizations. (Washington Post)...
by Family Voices, Inc. | Jan 5, 2022 | Family Voices, Vaccine Outreach
Today, CDC is updating our recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who received the Pfizer-BioNTech COVID-19 Vaccine. This means that people can now receive an mRNA booster shot 5...
by Family Voices, Inc. | Dec 17, 2021 | Family Voices, Vaccine Outreach
Científicos chinos encontraron que la velocidad con que la variante Ómicron se reproduce en el tejido bronquial supera a las otras variantes conocidas hasta hoy, pero no se comporta igual en los pulmones. Leer más aquí.